10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2014 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 24, 2015) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Revenues | |||
| Premiums | $ 68,389,800 | 66,119,100 | 56,496,700 |
| Administrative fees | 4,590,600 | 4,031,900 | 3,934,100 |
| Other revenue | 41,300 | 40,400 | 83,200 |
| Total operating revenue | 73,021,700 | 70,191,400 | 60,514,000 |
| Net investment income | 724,400 | 659,100 | 686,100 |
| Net realized gains on investments | 177,000 | 271,900 | 334,900 |
| Other than temporary impairment losses on investments: | |||
| Total other-than-temporary impairment losses on investments | (56,200) | (100,600) | (41,200) |
| Portion of other-than-temporary impairment losses recognized in other comprehensive income | 7,200 | 1,700 | 3,400 |
| Other-than-temporary impairment losses recognized in income | (49,000) | (98,900) | (37,800) |
| Total revenues | 73,874,100 | 71,023,500 | 61,497,200 |
| Expenses | |||
| Benefit expense | 56,854,900 | 56,237,100 | 48,213,600 |
| Selling, general and administrative expense: | |||
| Selling expense | 1,490,100 | 1,526,900 | 1,586,900 |
| General and administrative expense | 10,258,300 | 8,426,000 | 7,093,600 |
| Total selling, general and administrative expense | 11,748,400 | 9,952,900 | 8,680,500 |
| Interest expense | 600,700 | 602,700 | 511,800 |
| Amortization of other intangible assets | 220,900 | 245,300 | 233,000 |
| Loss on extinguishment of debt | 81,100 | 145,300 | 0 |
| Total expenses | 69,506,000 | 67,183,300 | 57,638,900 |
| Income from continuing operations before income tax expense | 4,368,100 | 3,840,200 | 3,858,300 |
| Income tax expense | 1,808,000 | 1,205,900 | 1,207,300 |
| Income from continuing operations | 2,560,100 | 2,634,300 | 2,651,000 |
| Income (loss) from discontinued operations, net of tax | 9,600 | (144,600) | 4,500 |
| Net income | 2,569,700 | 2,489,700 | 2,655,500 |
| Basic net income (loss) per share: | |||
| Basic - continuing operations (in dollars per share) | 9.28 | 8.83 | 8.25 |
| Basic - discontinued operations (in dollars per share) | 0.03 | (0.49) | 0.01 |
| Basic net income per share | 9.31 | 8.34 | 8.26 |
| Diluted net income (loss) per share: | |||
| Diluted - continuing operations (in dollars per share) | 8.96 | 8.67 | 8.17 |
| Diluted - discontinued operations (in dollars per share) | 0.03 | (0.47) | 0.01 |
| Diluted net income per share | 8.99 | 8.20 | 8.18 |
| Dividends per share | 1.75 | 1.50 | 1.15 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |